Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2

K Gohji1, I J Fidler, R Tsan

  • 1Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

International Journal of Cancer
|August 1, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence.

Prostate cancer and prostatic diseases·2002
Same author

Lack of prostate cancer radiosensitization by androgen deprivation.

International journal of radiation oncology, biology, physics·2001
Same author

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.

CA: a cancer journal for clinicians·2001
Same author

Spermatic cord sarcoma: outcome, patterns of failure and management.

The Journal of urology·2001
Same author

Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer.

Urology·2001
Same author

The challenge of prostate cancer.

CA: a cancer journal for clinicians·2001

Human recombinant interferons (r-IFNs), specifically beta and gamma, inhibit human renal-cell carcinoma (HRCC) invasion by suppressing gelatinase production. These effects are independent of antiproliferative actions, suggesting therapeutic potential for HRCC.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Human renal-cell carcinoma (HRCC) is a significant health concern.
  • Cancer cell invasion is a critical factor in metastasis and patient prognosis.
  • Gelatinases play a key role in extracellular matrix degradation, facilitating cancer cell invasion.

Purpose of the Study:

  • To investigate the effects of human recombinant interferons (r-IFNs) on gelatinase production and invasion by HRCC.
  • To determine if r-IFN-beta and r-IFN-gamma can inhibit the invasive potential of HRCC cells.

Main Methods:

  • Incubation of KG-2 HRCC cells with human r-IFN-beta, r-IFN-gamma, or r-IFN-alpha.
  • Assessing the transcription of the 72-kDa gelatinase gene.
  • Measuring gelatinase activity.

Related Experiment Videos

  • Evaluating cell invasion through a reconstituted basement membrane towards chemoattractants.
  • Testing the specificity of r-IFN effects on fibroblast gelatinase activity.

    • Main Results:

    • r-IFN-beta and r-IFN-gamma, but not r-IFN-alpha, suppressed 72-kDa gelatinase gene transcription and activity in KG-2 HRCC cells.
    • These inhibitory effects on gelatinase were independent of antiproliferative effects.
    • r-IFN-beta and r-IFN-gamma significantly inhibited KG-2 cell invasion through a reconstituted basement membrane.
    • The inhibitory activity of r-IFNs was specific to HRCC cells, with no effect on fibroblast gelatinase activity.

    Conclusions:

    • Human recombinant interferon-beta and interferon-gamma can effectively inhibit the invasive potential of human renal-cell carcinoma.
    • These interferons suppress gelatinase production, a key enzyme involved in cancer cell invasion.
    • r-IFN-beta and r-IFN-gamma represent potential therapeutic agents for managing HRCC invasion.